Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors

MeSH terms

• Animals
• Anti-HIV Agents / adverse effects*
• Anti-HIV Agents / pharmacology
• Anti-HIV Agents / therapeutic use
• Antiretroviral Therapy, Highly Active / adverse effects
• Female
• HIV Infections / drug therapy
• HIV Infections / prevention & control*
• Humans
• Infant, Newborn
• Lamivudine / adverse effects
• Lamivudine / pharmacology
• Lamivudine / therapeutic use
• Maternal-Fetal Exchange
• Pregnancy
• Prenatal Exposure Delayed Effects
• Reverse Transcriptase Inhibitors / adverse effects*
• Reverse Transcriptase Inhibitors / pharmacology
• Reverse Transcriptase Inhibitors / therapeutic use
• Risk Assessment
• Zidovudine / adverse effects
• Zidovudine / pharmacology
• Zidovudine / therapeutic use